Dec 20 (Reuters) - Bausch Health Companies Inc BHC.TO :
* BAUSCH HEALTH ANNOUNCES RESOLUTION OF BRYHALI® (HALOBETASOL PROPIONATE) LOTION, 0.01%, INTELLECTUAL PROPERTY LITIGATION WITH GLENMARK
* BAUSCH HEALTH COMPANIES INC - ORTHO DERMATOLOGICS WILL MAINTAIN MARKET EXCLUSIVITY FOR BRYHALI LOTION UNTIL 2026
* BAUSCH HEALTH COMPANIES - WILL GRANT GLENMARK A NON-EXCLUSIVE LICENSE EFFECTIVE 2026 TO ITS INTELLECTUAL PROPERTY RELATING TO BRYHALI LOTION IN U.S.
* BAUSCH HEALTH COMPANIES - CO & UNIT AGREED TO RESOLVE INTELLECTUAL PROPERTY LITIGATION WITH GLENMARK PHARMACEUTICALS REGARDING BRYHALI LOTION, 0.01%
* BAUSCH HEALTH COMPANIES INC - FINAL PATENT EXPIRY ON BRYHALI LOTION IS 2031